Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-96-030273
Filing Date
1996-12-27
Accepted
1996-12-27 00:00:00
Documents
7
Period of Report
1996-09-30
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 10-K405 10-K405 95525
2 LEASE BETWEEN DM SPECTRUM & MAXIM PHARMACUETICALS EX-10.16 187336
3 EXHIBIT 11.1 EX-11.1 2696
4 MAXIM PHARMACUETICALS A/R EX-13.1 90708
5 INDEPENDENT AUDITOR'S CONSENT EX-23.1 916
6 FINANCIAL DATA SCHEDULE EX-27 2308
7 INDEPENDENT AUDITOR'S REPORT EX-99 1994
  Complete submission text file 0000912057-96-030273.txt   383590
Mailing Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121 6194534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405 | Act: 34 | File No.: 001-14430 | Film No.: 96686689
SIC: 2833 Medicinal Chemicals & Botanical Products